Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | DSGN Design Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $12.12 -1.0% | $14.86 -2.5% |
| StockIQ Score | 38F Weak Risk: Medium | 36F Weak Risk: Medium |
| Technical | 19F | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 74B | 50C- |
| Quality | — | 50C- |
| Risk | 48D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Design Therapeutics (DSGN) scores higher overall, especially in technical (55 vs. 18) and investor confidence (48 vs. 37), signaling stronger market momentum and investor trust. Ascentage Pharma (AAPG) leads in growth (50 vs. 32), suggesting faster expansion potential. Both share equal valuation scores (38), but DSGN’s moderate rating contrasts with AAPG’s weak one.
